US2004081959A9PendingUtilityA9

Fluorescent quenching detection reagents and methods

Assignee: EPOCH BIOSCIENCES INCPriority: Dec 8, 1999Filed: Mar 29, 2002Published: Apr 29, 2004
Est. expiryDec 8, 2019(expired)· nominal 20-yr term from priority
C07F 9/6561C07F 9/572C07H 21/04C07H 21/00C40B 40/00C07C 245/08C07F 9/65522C07D 519/00C07F 9/2408C12Q 1/6818C07B 2200/11C09B 69/106C09B 29/0813
45
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Oligonucleotide probes containing two labels are provided and are useful in hybridization assays. The probes can also contain a minor groove binding group.

Claims

exact text as granted — not AI-modified
1 . An oligonucleotide probe compound having the formula:  
       
         
           
           
               
               
           
         
       
       wherein 
 Ar 1  and Ar 2  are each independently a substituted or unsubstituted aryl group, and one of Ar 1  and Ar 2  is directly or indirectly substituted with a substituted aryl group (Ar 3 ), where Ar 3  extends the resonance ability of the Ar 1 —N═N—Ar 2  aromatic system and thereby increases the wavelength absorbance maximum of the compound;  
 MGB is a minor groove binding group;  
 FL is a fluorescent group having an emission maxima in the region from about 400 to about 900 nm;  
 K is a cyclic or acyclic linking group having from 1 to 30 backbone atoms selected from C, N, O, S and P;  
 W is a linking group having from 3 to 100 backbone atoms selected from C, N, O, S, Si and P, said linking group being cyclic, acyclic, aromatic or a combination thereof;  
 [A—B] n  is a natural or modified oligonucleotide where the subscript n is an integer of from 4 to 100; and  
 the subscript zz is 0 or 1.  
 
     
     
         2 . A quencher-phosphoramidite reagent compound having the formula:  
       
         
           
           
               
               
           
         
       
       wherein 
 Ar 1  and Ar 2  are each independently a substituted or unsubstituted aryl group, and one of Ar 1  and Ar 2  is directly or indirectly substituted with a substituted aryl group (Ar 3 ), where Ar 3  extends the resonance ability of the Ar 1 —N═N—Ar 2  aromatic system and thereby increases the wavelength absorbance maximum of the compound;  
 X 1  is selected from the group consisting of H, (C 1 -C 12 )alkyl, aryl, heteroaryl, and protected or unprotected functional group;  
 X 2  is a moiety reactive towards nucleophiles; and  
 W is a linking group having from 3 to 100 backbone atoms selected from C, N, O, S, Si and P, said linking group being cyclic, acyclic, aromatic or a combination thereof.  
 
     
     
         3 . A compound of  claim 2  wherein X 2  is selected from the group consisting of a phosphorous coupling moiety, a pentafluorophenoxy moiety and a succinimidyl moiety.  
     
     
         4 . A compound of  claim 2  wherein X 1  is selected from the group consisting of OH, O-dimethoxytrityl, O-methoxytrityl, O-trityl or an oxygen atom having an acid labile blocking group.  
     
     
         5 . A compound of  claim 2  wherein X 2  is a phosphoramidite of the formula —O—P(N(iPr) 2 )(OCH 2 CH 2 CN).  
     
     
         6  A compound of claims  1  or  2  wherein Ar 2  is substituted with Ar 3 .  
     
     
         7  A compound of  claim 6  wherein Ar 2  is indirectly substituted with Ar 3 .  
     
     
         8 . A compound of  claim 7  wherein Ar 2  is indirectly substituted with Ar 3  through aromatic ring(s) and/or double bond(s).  
     
     
         9 . A compound of  claim 8  wherein Ar 2  is indirectly substituted with Ar 3  through a double bond selected from carbon-carbon and nitrogen-nitrogen double bonds.  
     
     
         10 . A compound of  claim 9  wherein Ar 2  is indirectly substituted with Ar 3  through a group selected from —(C≡C) t — and —(CR′═CR′) t — where t is 0 to 5 and R′ is independently selected from hydrogen, (C 1 -C 8 )alkyl and heteroalkyl, unsubstituted aryl and heteroaryl, (unsubstituted aryl)-(C 1 -C 4 )alkyl, and (unsubstituted aryl)oxy-(C 1 -C 4 )alkyl.  
     
     
         11 . A compound of claims  1  or  2  wherein at least one of Ar 1 , Ar 2  and Ar 3  is substituted with -halogen, —OR′, —OC(O)R′, —NR′R″, —SR′, —R′, —CN, —NO 2 , —CO 2 R′, —CONR′R″, —C(O)R′, —OC(O)NR′R″, —NR″C(O)R′, —NR″C(O) 2 R′, —NR′—C(O)NR″R′″, —NH—C(NH 2 )=NH, —NR′C(NH 2 )=NH, —NH—C(NH 2 )=NR′, —S(O)R′, —S(O) 2 R′, —S(O) 2 NR′R″, —N 3 , —CH(Ph) 2 , perfluoro(C 1 -C 4 )alkoxy, and perfluoro(C 1 -C 4 )alkyl, in a number ranging from zero to the total number of open valences on the aromatic ring system; and where R′, R″ and R′″ are independently selected from hydrogen, (C 1 -C 8 )alkyl and heteroalkyl, unsubstituted aryl and heteroaryl, (unsubstituted aryl)-(C 1 -C 4 )alkyl, and (unsubstituted aryl)oxy-(C 1 -C 4 )alkyl.  
     
     
         12 . A compound of  claim 11  wherein Ar 2  is indirectly substituted with Ar 3  through a double bond.  
     
     
         13  A compound of  claim 12 , wherein Ar 2 —N═N—Ar 1 — has the structure:  
       
         
           
           
               
               
           
         
       
     
     
         14 . A compound of  claim 11  wherein Ar 2  is directly substituted with Ar 3 .  
     
     
         15 . A compound of  claim 14  wherein Ar 2 —N═N—Ar 1 — has the structure:  
       
         
           
           
               
               
           
         
       
     
     
         16 . An oligonucleotide probe compound having the formula:  
       
         
           
           
               
               
           
         
       
       wherein 
 Ar 1  and Ar 2  are each independently a substituted or unsubstituted aryl group;  
 MGB is a minor groove binding group;  
 FL is a fluorescent group having an emission maxima in the region from about 400 to about 900 nm;  
 K is a cyclic or acyclic linking group having from 1 to 30 backbone atoms selected from C, N, O, S and P;  
 W is a linking group having from 3 to 100 backbone atoms selected from C, N, O, S, Si and P, said linking group being cyclic, acyclic, aromatic or a combination thereof, where W modulates the absorption wavelength of the Ar 1 —N═N—Ar 2  moiety to increase the wavelength absorbance of the compound;  
 [A—B] n  is a natural or modified oligonucleotide where the subscript n is an integer of from 4 to 100; and  
 the subscript zz is 0 or 1.  
 
     
     
         17 . A quencher-phosphoramidite reagent compound having the formula:  
       
         
           
           
               
               
           
         
       
       wherein 
 Ar 1  and Ar 2  are each independently a substituted or unsubstituted aryl group;  
 X 1  is selected from the group consisting of H, (C 1 -C 12 )alkyl, aryl, heteroaryl, and protected or unprotected functional group;  
 X 2  is a moiety reactive towards nucleophiles; and  
 W is a linking group having from 3 to 100 backbone atoms selected from C, N, O, S, Si and P, said linking group being cyclic, acyclic, aromatic or a combination thereof, where W modulates the absorption wavelength of the Ar 1 —N═N—Ar 2  moiety to increase the wavelength absorbance of the compound.  
 
     
     
         18 . A compound of  claim 17  wherein X 2  is selected from the group consisting of a phosphorous coupling moiety, a pentafluorophenoxy moiety and a succinimidyl moiety.  
     
     
         19 . A compound of claims  16  or  17  wherein W comprises a substituted aryl group (Ar 3 ) which is directly or indirectly attached to Ar 1  and extends the resonance ability of the Ar 1 —N═N—Ar 2  aromatic system and thereby increases the wavelength absorbance maximum of the compound.  
     
     
         20 . A compound of  claim 19  wherein Ar 1  is indirectly substituted with Ar 3  through aromatic ring(s) and/or double bond(s).  
     
     
         21 . A compound of  claim 20  wherein Ar 1  is indirectly substituted with Ar 3  through a double bond selected from carbon-carbon and nitrogen-nitrogen double bonds.  
     
     
         22 . A compound of  claim 21  wherein Ar 1  is indirectly substituted with Ar 3  through a group selected from —(C≡C) t — and —(CR′═CR′) t — where t is 0 to 5 and R′ is independently selected from hydrogen, (C 1 -C 8 )alkyl and heteroalkyl, unsubstituted aryl and heteroaryl, (unsubstituted aryl)-(C 1 -C 4 )alkyl, and (unsubstituted aryl)oxy-(C 1 -C 4 )alkyl.  
     
     
         23 . A probe compound-for a hybridization assay comprising the formula FL-ODN-(W) d -Q wherein 
 FL is a fluorophore with an emission wavelength in the range of about 300 to about 800 nm;    ODN is an oligonucleotide;    W is a linker group that has from 3 to 100 atoms other than hydrogen atoms, selected from C, N, O, S, P and Si, and is cyclic, acyclic, aromatic or a combination thereof, and d is 0 or 1; and    Q is a quencher moiety comprising the structure —Ar 1 —N═N—Ar 2  wherein Ar 1  is joined to either ODN or W, and Q has a broader absorbance range than dabcyl (4-{[4-(dimethylamino)phenyl]diazenyl}benzoyl, absorbance max=453 nm), wherein Ar 1  and Ar 2  are each independently a substituted or unsubstituted aryl group.    
     
     
         24 . A compound of  claim 23  wherein one of Ar 1  and Ar 2  is directly or indirectly substituted with a substituted aryl group (Ar 3 ), where Ar 3  extends the resonance ability of the Ar 1 —N═N—Ar 2  aromatic system and thereby increases the wavelength absorbance maximum of the compound.  
     
     
         25 . A compound of the formula  
       
         
           
           
               
               
           
         
       
       wherein  
       
         
           
           
               
               
           
         
         L is a cleavable linker;  
         q is 0 or 1;  
         MGB is a minor groove binder;  
         r is 0 or 1;  
         W is a linker group that has from 3 to 100 atoms other than hydrogen atoms, selected from C, N, O, S, P and Si, and is cyclic, acyclic, aromatic or a combination thereof;  
         Q is a quencher moiety comprising the formula —Ar 1 —N═N—Ar 2  where Ar 1  is joined to W and wherein Ar 1  and Ar 2  are each independently a substituted or unsubstituted aryl group, and one of Ar 1  and Ar 2  is directly or indirectly substituted with a substituted aryl group (Ar 3 ), where Ar 3  extends the resonance ability of the Ar 1 —N═N—Ar 2  aromatic system and thereby increases the wavelength absorbance maximum of the compound; and  
         Y is selected from 
 —O—J 1  where J 1  is a hydroxyl protecting group;  
 an oligonucleotide (-ODN); and  
 an oligonucleotide-fluorophore conjugate (-ODN-FL).  
 
       
     
     
         26 . A compound of claims  24  or  25  wherein Ar 2  is indirectly substituted with Ar 3  through aromatic ring(s) and/or double bond(s).  
     
     
         27 . A compound of  claim 26  wherein Ar 2  is indirectly substituted with Ar 3  through a double bond selected from carbon-carbon and nitrogen-nitrogen double bonds.  
     
     
         28 . A compound of claims  24  or  25  wherein W comprises Ar 3 , and Ar 1  is indirectly substituted with Ar 3  through aromatic ring(s) and/or double bond(s).  
     
     
         29 . A compound of  claim 28  wherein Ar 1  is indirectly substituted with Ar 3  through a double bond selected from carbon-carbon and nitrogen-nitrogen double bonds.  
     
     
         30 . A compound of  claim 25  wherein q is 0.  
     
     
         31 . A compound of  claim 25  wherein the solid support is selected from glass, controlled pore glass, polymeric materials, polystyrene, beads, coated glass or support that is compatible with oligonucleotide synthesis.

Join the waitlist — get patent alerts

Track US2004081959A9 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.